Familial mediterranean fever diagnostic study of choice: Difference between revisions

Jump to navigation Jump to search
(/* The Livneh criteria for diagnosing familial Mediterranean fever{{cite journal |vauthors=Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A, Padeh S, Pras M |title=Criteria for the diagnosis of familial Mediterranean fever |journal=Art...)
No edit summary
Line 12: Line 12:
There is another set of criteria for the diagnosis of [[FMF]] in children.
There is another set of criteria for the diagnosis of [[FMF]] in children.
Since [[FMF]] occurs due to a [[mutation]] in [[MEFV]] [[gene]], [[genetic analysis]] is also available for the [[diagnosis]]. However, it would not be cost-effective.
Since [[FMF]] occurs due to a [[mutation]] in [[MEFV]] [[gene]], [[genetic analysis]] is also available for the [[diagnosis]]. However, it would not be cost-effective.
==== The comparison of various [[diagnostic]] studies for [[Familial mediterranean fever|familial Mediterranean fever]]====
==== The Tel Hashomer for [[Diagnosis|diagnosing]] [[Familial mediterranean fever|familial Mediterranean fever]]====
{|
{| class="wikitable"
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
|+
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | Test
|-
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Sensitivity
| align="center" style="background:#f0f0f0;" |'''Major criteria'''
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Specificity
|-
|1. Recurrent episodes of [[fever]] plus [[serositis]]
|-
|2. AA type of [[amyloidosis]] without predisposing [[disease]]
|-
|3. Response to [[colchicine]]
|-
|+
!Minor criteria
|-
|-
! style="background: #696969; color: #FFFFFF; text-align: center;" |Tel Hashomer criteria
|1. Recurrent febrile attacks
| style="background: #DCDCDC; padding: 5px; text-align: center;" |%
| style="background: #DCDCDC; padding: 5px; text-align: center;" |%
|-
|-
! style="background: #696969; color: #FFFFFF; text-align: center;" |Livneh criteria
|2. [[Erysipelas]]-like [[erythema]]
| style="background: #DCDCDC; padding: 5px; text-align: center;" |%
| style="background: #DCDCDC; padding: 5px; text-align: center;" |%
|}
 
==== The Tel Hashomer for [[Diagnosis|diagnosing]] [[Familial mediterranean fever|familial Mediterranean fever]]====
{|
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | Type
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Criteria
|-
|-
! style="background: #696969; color: #FFFFFF; text-align: center;" |Major
|3. Family history in first-degree relatives
| style="background: #DCDCDC; padding: 5px; text-align: left;" |1. Recurrent episodes of fever plus serositis
 
2. AA type of amyloidosis without predisposing disease
 
3. Response to colchicine
|-
|-
! style="background: #696969; color: #FFFFFF; text-align: center;" |Minor
| style="background: #DCDCDC; padding: 5px; text-align: left;" |1. Recurrent febrile attacks
2. Erysipelas-like erythema
3. Family history in first-degree relatives
|}
|}
The definitive [[diagnosis]] requires at least two major criteria or one major plus two minor criteria.
The definitive [[diagnosis]] requires at least two major criteria or one major plus two minor criteria.
Line 114: Line 100:
*≥1 minor criterion plus ≥5 supportive criteria
*≥1 minor criterion plus ≥5 supportive criteria
*≥1 minor criterion plus ≥4 of the five supportive criteria
*≥1 minor criterion plus ≥4 of the five supportive criteria
==== The comparison of various [[diagnostic]] studies for [[Familial mediterranean fever|familial Mediterranean fever]]====
{|
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | Test
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Sensitivity
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Specificity
|-
! style="background: #696969; color: #FFFFFF; text-align: center;" |Tel Hashomer criteria
| style="background: #DCDCDC; padding: 5px; text-align: center;" |%
| style="background: #DCDCDC; padding: 5px; text-align: center;" |%
|-
! style="background: #696969; color: #FFFFFF; text-align: center;" |Livneh criteria
| style="background: #DCDCDC; padding: 5px; text-align: center;" |%
| style="background: #DCDCDC; padding: 5px; text-align: center;" |%
|}


==Genetic analysis==
==Genetic analysis==

Revision as of 23:23, 4 June 2019

Familial Mediterranean Fever Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Familial Mediterranean Fever from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X ray

Echocardiography and Ultrasound

CT scan

MRI

Other imaging Studies

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary prevention

Secondary prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Familial mediterranean fever diagnostic study of choice On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Familial mediterranean fever diagnostic study of choice

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Familial mediterranean fever diagnostic study of choice

CDC on Familial mediterranean fever diagnostic study of choice

Familial mediterranean fever diagnostic study of choice in the news

Blogs on Familial mediterranean fever diagnostic study of choice

Directions to Hospitals Treating Familial mediterranean fever

Risk calculators and risk factors for Familial mediterranean fever diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]

Overview

Familial Mediterranean fever is primarily diagnosed based on the clinical presentation.

Diagnostic Study of Choice

Study of choice

Familial Mediterranean fever is primarily diagnosed based on the clinical presentation. There are two sets of criteria for the diagnosis of this disorder in adults, including:[1]

  • Tel Hashomer criteria, which is used widely
  • Livneh criteria, which is developed recently.

There is another set of criteria for the diagnosis of FMF in children. Since FMF occurs due to a mutation in MEFV gene, genetic analysis is also available for the diagnosis. However, it would not be cost-effective.

The Tel Hashomer for diagnosing familial Mediterranean fever

Major criteria
1. Recurrent episodes of fever plus serositis
2. AA type of amyloidosis without predisposing disease
3. Response to colchicine
Minor criteria
1. Recurrent febrile attacks
2. Erysipelas-like erythema
3. Family history in first-degree relatives

The definitive diagnosis requires at least two major criteria or one major plus two minor criteria.

The Livneh criteria for diagnosing familial Mediterranean fever[1]

Major criteria
Typical attacks (recurrent (≥3 of the same type), febrile rectal temperature ≥38 °C lasting 12 h and 3 days)
Peritonitis (generalized)
Pleuritis (unilateral) or pericarditis
Monoarthritis (hip, knee, ankle)
Fever alone
Minor criteria
Incomplete attacks involving one or more of the following sites (1–3)
Painful/recurrent attacks that differ from typical attacks in one or two features: (a) the temperature is normal or lower than 38 °C; (b) the attacks are longer or shorter than specified (but not shorter than 6 h or longer than a week);(c) no signs of peritonitis are recorded during the abdominal attacks; (d) the abdominal attacks are localized; and (e) the arthritis is in joints other than those specified
1.Abdomen
2.Chest
3.Joint
4.Exertional leg pain
5. Favorable response to colchicine
Supportive criteria
1. Family history of FMF
2. Appropriate ethnic origin
3. Age <20 years at disease onset
Features of attack (4–7)
4. Severe requiring bed rest
5. Spontaneous remission
6. Symptom-free interval
7. Transient inflammatory response with one or more test result(s) for white blood cell count, ESR, SAA, and/or fibrinogen
8. Episodic proteinuria/hematuria
9. Unproductive laparatomy or removal of white appendix
10. Consanguinity of parents

The diagnosis of FMF is made in case of

  • At least one major criterion
  • At least two minor criteria
  • ≥1 minor criterion plus ≥5 supportive criteria
  • ≥1 minor criterion plus ≥4 of the five supportive criteria

The comparison of various diagnostic studies for familial Mediterranean fever

Test Sensitivity Specificity
Tel Hashomer criteria % %
Livneh criteria % %

Genetic analysis

Genetic analysis is recommended according to the following algorithm.

 
 
An individual with unexplained fever + High CRP
 
Those who meet diagnostic criteria
(Attack duration <3 days)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ask for accompanying features:
1.Any skin rash other than erysipelas-like erythema
2.Oral ulcers, psoriasis, panniculitis
3.Exudative pharyngitis during attacks
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
None of the above
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MEFV gene analysis recommended
 
 
The above algorithm adopted from Nature review rheumatology [2]

References

  1. 1.0 1.1 Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A, Padeh S, Pras M (October 1997). "Criteria for the diagnosis of familial Mediterranean fever". Arthritis Rheum. 40 (10): 1879–85. doi:10.1002/1529-0131(199710)40:10<1879::AID-ART23>3.0.CO;2-M. PMID 9336425.
  2. Ozen S, Bilginer Y (March 2014). "A clinical guide to autoinflammatory diseases: familial Mediterranean fever and next-of-kin". Nat Rev Rheumatol. 10 (3): 135–47. doi:10.1038/nrrheum.2013.174. PMID 24247370.